Drug development in biotechnology takes time. A lot of time. On average, it takes 10 to 15 years to take a medicine from ...

Their data suggests that tweaking the expression of FDX2 could make up for the loss of frataxin, the protein tied to FA's development.

Leading synthetic biologists have shared hard-won lessons from their decade-long quest to build the world's first synthetic ...

Ph.D. student Ziqi Zhang has built a career blending machine learning with single-cell biology. His work helps scientists study cellular mechanisms that advances disease research and drug development.

A cutting-edge therapy using base-edited immune cells is offering a major breakthrough for patients with one of the toughest ...

Today's biomedical researchers are relentlessly searching for genes that drive disease, with the goal of creating therapies ...

Analysis of more than one million people shows that mental-health disorders fall into five clusters, each of them linked to a ...

Friedreich's ataxia (FA) is a rare but devastating genetic disorder. Those with the condition are often diagnosed between 5 ...

The rollout of a type of genetic technology called a gene drive for tackling malaria could be edging closer after a lab study ...

Friedreich's ataxia (FA) is a rare but devastating genetic disorder. Those with the condition are often diagnosed between 5 and 15 years of age and ...

Arpita Bose and Zhecheng Zhang explore genetic tools in environmental microbes, citing applications in extracellular electron transfer ...

The global synthetic biology market is poised for exponential growth, driven by a myriad of factors including increasing investments by government and private players, rising R&D funding and ...